Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zanelli

Showing results (731-740 of 753) with videos related to

Pageof 76
Sort By:
Plos Neglected Tropical Diseases|October 5, 2020
Trypanosomatid selenophosphate synthetase structure, function and interaction with selenocysteine lyaseMarco Túlio Alves da Silva, Ivan Rosa E Silva, Lívia Maria Faim, et al.
Iscience|June 5, 2023
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutationsCamilla Tiezzi, Andrea Vecchi, Marzia Rossi, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor MicroenvironmentAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patientsMaria Lucia Iacovino, Laura Arenare, Alessandro Morabito, et al.
Cancers|September 13, 2025
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature ReviewAndrea Palicelli, Gabriele Tonni, Federica Torricelli, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation VariablesAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Pediatric Research|September 18, 2025
Benefits and risks of therapeutic hypothermia for hypoxic-ischemic encephalopathy in late preterm infantsMohamed El-Dib, Dalal Abdelgadir, Kaashif A Ahmad, et al.
Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.
Pageof 76

Showing results (731-740 of 753) with videos related to

Sort By:
Pageof 76
Plos Neglected Tropical Diseases|October 5, 2020
Trypanosomatid selenophosphate synthetase structure, function and interaction with selenocysteine lyaseMarco Túlio Alves da Silva, Ivan Rosa E Silva, Lívia Maria Faim, et al.
Iscience|June 5, 2023
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutationsCamilla Tiezzi, Andrea Vecchi, Marzia Rossi, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor MicroenvironmentAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patientsMaria Lucia Iacovino, Laura Arenare, Alessandro Morabito, et al.
Cancers|September 13, 2025
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature ReviewAndrea Palicelli, Gabriele Tonni, Federica Torricelli, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation VariablesAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Pediatric Research|September 18, 2025
Benefits and risks of therapeutic hypothermia for hypoxic-ischemic encephalopathy in late preterm infantsMohamed El-Dib, Dalal Abdelgadir, Kaashif A Ahmad, et al.
Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.
Pageof 76